Promising Prospects for Acurx Pharmaceuticals: Buy Rating Backed by Ibezapolstat’s Efficacy and Strategic Positioning
In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Acurx Pharmaceuticals (ACXP – Research ...